Detalles de la búsqueda
1.
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
Br J Haematol
; 204(3): 892-897, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38013238
2.
Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms.
Br J Haematol
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38639421
3.
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.
Eur J Haematol
; 109(6): 755-764, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36063368
4.
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
Antimicrob Agents Chemother
; 64(2)2020 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31712211
5.
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
Br J Haematol
; 191(1): 52-61, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32510599
6.
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
Eur J Haematol
; 105(2): 138-147, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243655
7.
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
Am J Hematol
; 92(7): 614-621, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370234
8.
Excess mortality in the myelodysplastic syndromes.
Am J Hematol
; 92(2): 149-154, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27859564
9.
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Mod Pathol
; 29(12): 1541-1551, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27562492
10.
Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.
Eur J Haematol
; 97(1): 33-8, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341961
11.
Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients.
Respirology
; 21(8): 1411-1418, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27417156
12.
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Mycoses
; 59(8): 516-9, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27027972
13.
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease.
Croat Med J
; 57(3): 247-54, 2016 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27374826
14.
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
Clin Infect Dis
; 59(12): 1696-702, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25165088
15.
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Haematol
; 11(1): e38-e50, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38065203
16.
Biological basis of extensive pleiotropy between blood traits and cancer risk.
Genome Med
; 16(1): 21, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38308367
17.
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8.
Cancers (Basel)
; 15(15)2023 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568638
18.
Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.
J Geriatr Oncol
; 14(1): 101401, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404260
19.
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
Blood Cancer J
; 13(1): 69, 2023 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37147301
20.
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
Blood Adv
; 7(13): 3117-3127, 2023 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36724515